Search - tctmd.com

Displaying 441 - 460 of 903

Sort: Relevancy | Date

Presentation TCT 2018

The New 2018 ESC/EACTS Guidelines on Myocardial Revascularization: Focus on Multivessel and Left Main Disease

Presenter: Jeroen J. Bax, Stephan Windecker, Robert A. Byrne

September 21, 2018

Presentation ESC 2018

2018 ESC/EACTS Guidelines on Myocardial Revascularization

Presenter: Franz-Josef Neumann

August 30, 2018

Presentation ESC 2018

FUnctional Testing Underlying REvascularization The FUTURE trial

Presenter: Gilles Rioufol

August 26, 2018

Presentation The Structural Heart Disease Summit 2018

Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization)

Presenter: Torsten P. Vahl

June 21, 2018

Presentation SCAI 2018

The Prognostic Impact of Revascularization Strategy in Acute Myocardial Infarction and Cardiogenic Shock

Presenter: Andrew McNeice

April 28, 2018

Presentation SCAI 2018

PERSPECTIVE Trial: Percutaneous Revascularization at Piedmont for Chronic Total Occlusions Survey

Presenter: David E. Kandzari

April 28, 2018

Presentation

Hybrid Coronary Revascularization (HRC) in Selected Patients With Multivessel Disease

April 23, 2018

Presentation

Mortality Following Nonemergent, Uncomplicated TLR After PCI

April 20, 2018

Presentation Fellows 2018

Complete Revascularization of Complex Higher Risk (and Indicated) Patients: The Rationale

Presenter: Gary S. Mintz, Jeffrey W. Moses

April 14, 2018

Presentation CIT 2018

Best Practice for PCI: Lessons from SYNTAX II

Presenter: Patrick W. Serruys

March 23, 2018

Presentation ACC 2018

A Phase II Randomized Double-Blind, Placebo Controlled Study in Patients with Critical Limb Ischemia to Evaluate the Safety and Efficacy of hSDF-1 plasmid (JVS-100) Post Open or Endovascular Revascularization (STOP-PAD Trial)

Presenter: Mehdi H. Shishehbor

March 12, 2018

Presentation CHIP at ACC 2018

Opening Salvo: Where PCI Needs to Go in the Next 5-10 Years

Presenter: Martin B. Leon

March 09, 2018

Presentation JIM 2018

Left Ventricular Support During Complex Transradial Percutaneous Coronary Intervention for Complete Revascularization

Presenter: Carlo Briguori

February 23, 2018

Presentation

Complete vs Culprit-Only Revascularization in STEMI With Multivessel Disease

February 15, 2018

Presentation TTT 2018

Should we revascularized CTO lesions? Decision CTO vs Euro CTO trial

Presenter: Alfredo R. Galassi

January 14, 2018

Presentation Controversies and Advances 2017

FFR is the Gold Standard For Revascularization Decision Making

Presenter: Matthew J. Price

November 17, 2017

Presentation Controversies and Advances 2017

FFR is NOT the Gold Standard for Revascularization Decision Making

Presenter: Paul S. Teirstein

November 17, 2017

Presentation TCT 2017

TAVR in AS Patients With Stable Coronary Disease: Evolving Treatment Issues (When to Consider CABG, Timing of PCI, and Completeness of Revascularization)

Presenter: Torsten P. Vahl

November 01, 2017

Presentation TCT 2017

Case #2 Conclusion: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How We Treated

Presenter: David J. Maron, Alan C. Yeung, Vasim Farooq

November 01, 2017

Presentation TCT 2017

Case #3 Introduction: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How Should We Treat?

Presenter: David J. Maron, Alan C. Yeung, Vasim Farooq

November 01, 2017

Advertisement

The New 2018 ESC/EACTS Guidelines on Myocardial Revascularization: Focus on Multivessel and Left Main Disease

2018 ESC/EACTS Guidelines on Myocardial Revascularization

FUnctional Testing Underlying REvascularization The FUTURE trial

Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization)

The Prognostic Impact of Revascularization Strategy in Acute Myocardial Infarction and Cardiogenic Shock

PERSPECTIVE Trial: Percutaneous Revascularization at Piedmont for Chronic Total Occlusions Survey

Hybrid Coronary Revascularization (HRC) in Selected Patients With Multivessel Disease

Mortality Following Nonemergent, Uncomplicated TLR After PCI

Complete Revascularization of Complex Higher Risk (and Indicated) Patients: The Rationale

Best Practice for PCI: Lessons from SYNTAX II

A Phase II Randomized Double-Blind, Placebo Controlled Study in Patients with Critical Limb Ischemia to Evaluate the Safety and Efficacy of hSDF-1 plasmid (JVS-100) Post Open or Endovascular Revascularization (STOP-PAD Trial)

Opening Salvo: Where PCI Needs to Go in the Next 5-10 Years

Left Ventricular Support During Complex Transradial Percutaneous Coronary Intervention for Complete Revascularization

Complete vs Culprit-Only Revascularization in STEMI With Multivessel Disease

Should we revascularized CTO lesions? Decision CTO vs Euro CTO trial

FFR is the Gold Standard For Revascularization Decision Making

FFR is NOT the Gold Standard for Revascularization Decision Making

TAVR in AS Patients With Stable Coronary Disease: Evolving Treatment Issues (When to Consider CABG, Timing of PCI, and Completeness of Revascularization)

Case #2 Conclusion: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How We Treated

Case #3 Introduction: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How Should We Treat?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content